- Home
- EXEL
EXEL
Exelixis Inc.
as 04-18-2025 1:35pm EST
| Founded: | 1994 | Country: | United States |
| Employees: | N/A | City: | ALAMEDA |
| Market Cap: | N/A | IPO Year: | 2000 |
| Target Price: | $37.59 | AVG Volume (30 days): | 2.8M |
| Analyst Decision: | Buy | Number of Analysts: | 18 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.76 | EPS Growth: | 170.77 |
| 52 Week Low/High: | $20.14 - $40.02 | Next Earning Date: | 04-29-2025 |
| Revenue: | $2,168,701,000 | Revenue Growth: | 18.50% |
| Revenue Growth (this year): | 5.82% | Revenue Growth (next year): | 10.81% |
Stock Insider Trading Activity of Exelixis Inc. (EXEL)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Haley Patrick J. | EXEL | EVP, Commercial | Mar 3 '25 | Sell | $38.80 | 10,000 | $388,000.00 | 341,028 | |
| WYSZOMIERSKI JACK L | EXEL | Director | Feb 28 '25 | Sell | $37.80 | 8,768 | $331,430.40 | 356,605 | |
| Smith Julie | EXEL | Director | Feb 27 '25 | Sell | $37.88 | 73,808 | $2,804,459.10 | 10,778 | |
| Oliver Bob | EXEL | Director | Feb 25 '25 | Sell | $37.25 | 18,647 | $694,600.75 | 33,514 | |
| Haley Patrick J. | EXEL | EVP, Commercial | Feb 24 '25 | Sell | $36.98 | 52,636 | $1,946,479.28 | 341,028 | |
| Aftab Dana | EXEL | CSO/EVP Disc & Trans Research | Feb 24 '25 | Sell | $36.75 | 26,987 | $991,772.25 | 511,908 | |
| Senner Christopher J. | EXEL | EVP and CFO | Feb 24 '25 | Sell | $36.14 | 29,314 | $1,059,407.96 | 779,607 | |
| Beckerle Mary C | EXEL | Director | Feb 14 '25 | Sell | $34.89 | 12,210 | $425,878.38 | 34,262 | |
| Eckhardt Sue Gail | EXEL | Director | Feb 14 '25 | Sell | $35.03 | 11,568 | $405,111.36 | 30,406 | |
| Freire Maria C | EXEL | Director | Feb 14 '25 | Sell | $34.94 | 44,114 | $1,541,343.16 | 91,007 |
Latest Exelixis Inc. News
EXEL Breaking Stock News: Dive into EXEL Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 days ago
High Growth Tech Stocks To Watch In The US April 2025
Zacks
3 days ago
Why Exelixis (EXEL) is a Top Momentum Stock for the Long-Term
Argus Research
4 days ago
EXEL: Raising target price to $40.00
Zacks
8 days ago
Will Exelixis (EXEL) Beat Estimates Again in Its Next Earnings Report?
Zacks
8 days ago
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
Argus Research
11 days ago
EXEL: Lowering target price to $37.00
Zacks
11 days ago
Why Exelixis (EXEL) is a Top Value Stock for the Long-Term
Motley Fool
16 days ago
The Smartest Biotech Stocks to Buy With $50
Compare EXEL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EXEL Exelixis Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.